Simon Fage

Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis

Sonja Ständer, Gil Yosipovitch, Franz J. Legat et al. · JAMA Dermatology · 2024 · 51 citations · Full text

Medicine, Dermatology, Pharmacotherapy +13

Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO)

Mette Gyldenløve, Howraman Meteran, Jennifer Astrup Sørensen et al. · The Lancet Regional Health - Europe · 2023 · 41 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Abatacept Improves Skin-score and Reduces Lesions in Patients with Localized Scleroderma: A Case Series

Simon Fage, Kristian Bakke Arvesen, Anne Braae Olesen · Acta Dermato Venereologica · 2018 · 31 citations · Full text

Medicine, Dermatology, Immunology +7

Effectiveness of brodalumab after previous treatment failure of interleukin‐<scp>17A</scp> inhibitors in patients with psoriasis

Nikolai Loft, Anne Bregnhøj, Simon Fage et al. · Dermatologic Therapy · 2021 · 20 citations

Medicine, Immunology, Pharmacotherapy +17

Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis – results from a randomized controlled trial (PSORRO)

Mette Gyldenløve, Jennifer Astrup Sørensen, Simon Fage et al. · Journal of the American Academy of Dermatology · 2024 · 11 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15